UCB Pharma Canada appoints general manager
This article was originally published in Scrip
Executive Summary
UCB Pharma Canada, a biopharmaceutical company specialising in autoimmune and central nervous system disease therapies, has appointed Anne de Cassini as general manager. She has 22 years' experience within the pharmaceutical industry; prior to her new role, she served as general manager of UCB's central nervous system business operation in France.